- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 144-158 of
1,170 results
No. 200
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 200 (N.D.W.Va. Jul. 8, 2024)
|
|
Cite Document
No. 192
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 192 (N.D.W.Va. Jul. 3, 2024)
|
|
Cite Document
No. 189
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 189 (N.D.W.Va. Jun. 28, 2024)
|
|
Cite Document
No. 364
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 364 (N.D.W.Va. Mar. 24, 2023)
|
|
Cite Document
No. 187
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 187 (N.D.W.Va. Jun. 26, 2024)
|
|
Cite Document
70 Motion Other: Patent Owners Motion to Expunge
Document
IPR2023-00884, No. 70 Motion Other - Patent Owners Motion to Expunge (P.T.A.B. Sep. 4, 2024)
|
|
Cite Document
No. 315
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 315 (N.D.W.Va. Feb. 17, 2023)
|
|
Cite Document
No. 299
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 299 (N.D.W.Va. Feb. 6, 2023)
|
|
Cite Document
9 Institution Decision Deny: Denying Institution of Inter Partes Review 35 USC § 314
Document
IPR2022-01524, No. 9 Institution Decision Deny - Denying Institution of Inter Partes Review 35 USC § 314 (P.T.A.B. Mar. 10, 2023)
|
|
Cite Document
No. 156
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 156 (N.D.W.Va. Apr. 11, 2024)
|
|
Cite Document
No. 622
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 622 (N.D.W.Va. Sep. 1, 2023)
|
|
Cite Document
No. 627
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 627 (N.D.W.Va. Sep. 1, 2023)
|
|
Cite Document
No. 613
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 613 (N.D.W.Va. Sep. 1, 2023)
|
|
Cite Document
No. 612
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 612 (N.D.W.Va. Sep. 1, 2023)
|
|
Cite Document
No. 632
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 632 (N.D.W.Va. Sep. 1, 2023)
|
|
Cite Document
